GUK1 is a novel metabolic liability in oncogene-driven lung cancer

被引：0
|
作者：
Schneider, Jaime Laurel
Kurmi, Kiran
Dhiman, Ishita
Colapietro, Roberta
Joshi, Shakchhi
Johnson, Christian
Yoda, Satoshi
Paulo, Joao
Ruiz, Daniela
Stopka, Sylwia
Baquer, Gerard
Lin, Jessica
Haigis, Kevin
Agar, Nathalie
Gygi, Steven
Hata, Aaron
Haigis, Marcia
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-1156
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1156
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Surveillance brain imaging in oncogene-driven non-small cell lung cancer: The Kent Oncology Centre experience
    Tippu, Zayd
    Shah, Riyaz
    [J]. LUNG CANCER, 2021, 156 : S21 - S22
  • [42] Tumor response to simultaneous PDK1 knockdown and inhibition of EGFR signaling in oncogene-driven non-small cell lung cancer
    De Rosa, V.
    Iommelli, F.
    Terlizzi, C.
    Del Vecchio, S.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S501 - S501
  • [43] Targeted therapies prime oncogene-driven lung cancers for macrophage-mediated destruction
    Vaccaro, Kyle
    Allen, Juliet
    Whitfield, Troy W.
    Maoz, Asaf
    Reeves, Sarah
    Velarde, Jose
    Yang, Dian
    Meglan, Anna
    Ribeiro, Juliano
    Blandin, Jasmine
    Phan, Nicole
    Bell, George W.
    Hata, Aaron N.
    Weiskopf, Kipp
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2024, 134 (09):
  • [44] The GATA2 Transcriptional Network is Requisite for Ras Oncogene-driven Non-small Cell Lung Cancer
    Kumar, M. S.
    Downward, J.
    [J]. EUROPEAN JOURNAL OF CANCER, 2012, 48 : S121 - S121
  • [45] The GATA2 Transcriptional Network Is Requisite for RAS Oncogene-Driven Non-Small Cell Lung Cancer
    Kumar, Madhu S.
    Hancock, David C.
    Molina-Arcas, Miriam
    Steckel, Michael
    East, Phillip
    Diefenbacher, Markus
    Armenteros-Monterroso, Elena
    Lassailly, Francois
    Matthews, Nik
    Nye, Emma
    Stamp, Gordon
    Behrens, Axel
    Downward, Julian
    [J]. CELL, 2012, 149 (03) : 642 - 655
  • [46] High prevalence of pathogenic germline variants in patients with oncogene-driven non-small cell lung cancer.
    Mezquita, Laura
    Iurchenko, Andrei
    Benitez, Jose Carlos
    Baz, Maria
    Nikolaev, Sergey
    Planchard, David
    Blanc-Durand, Felix
    Aldea, Mihaela
    Martin-Romano, Patricia
    Loriot, Yohann
    Nicotra, Claudio
    Ngocamus, Maud
    Scoazec, Jean-Yves
    Michiels, Stefan
    Postel-Vinay, Sophie
    Viot, Julien
    Friboulet, Luc
    Italiano, Antoine
    Andre, Fabrice
    Massard, Christophe
    Soria, Jean-Charles
    Rouleau, Etienne
    Gautheret, Daniel
    Besse, Benjamin
    [J]. CANCER RESEARCH, 2021, 81 (13)
  • [47] Efficacy of immunotherapy in patients with oncogene-driven non-small-cell lung cancer: a systematic review and meta-analysis
    Chen, Jiayan
    Lu, Wanjun
    Chen, Mo
    Cai, Zijing
    Zhan, Ping
    Liu, Xin
    Zhu, Suhua
    Ye, Mingxiang
    Lv, Tangfeng
    Lv, Jiawen
    Song, Yong
    Wang, Dong
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16
  • [48] Emerging therapeutics and evolving assessment criteria for intracranial metastases in patients with oncogene-driven non-small-cell lung cancer
    Kelsey Pan
    Kyle Concannon
    Jing Li
    Jianjun Zhang
    John V. Heymach
    Xiuning Le
    [J]. Nature Reviews Clinical Oncology, 2023, 20 : 716 - 732
  • [49] Emerging therapeutics and evolving assessment criteria for intracranial metastases in patients with oncogene-driven non-small-cell lung cancer
    Pan, Kelsey
    Concannon, Kyle
    Li, Jing
    Zhang, Jianjun
    Heymach, John V. V.
    Le, Xiuning
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2023, 20 (10) : 716 - 732
  • [50] Intrinsic and Extrinsic Regulation of PD-L2 Expression in Oncogene-Driven Non-Small Cell Lung Cancer
    Shibahara, Daisuke
    Tanaka, Kentaro
    Iwama, Eiji
    Kubo, Naoki
    Ota, Keiichi
    Azuma, Koichi
    Harada, Taishi
    Fujita, Jiro
    Nakanishi, Yoichi
    Okamoto, Isamu
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (07) : 926 - 937
12345